Iowanews Headlines

As per DelveInsight’s assessment, The growth of the artificial intelligence in remote patient monitoring market is largely fueled by the rising prevalence of chronic diseases, the expanding adoption of telehealth and digital healthcare solutions, innovations in wearable and IoT-enabled medical devices, and the increasing collaborations and partnerships among pharmaceutical and medical device companies.

DelveInsight’s “Artificial Intelligence (AI) in Remote Patient Monitoring Market Insights, Competitive Landscape, and Market Forecast – 2034” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Artificial Intelligence (AI) in Remote Patient Monitoring companies actively working in the market.

Explore the future of healthcare innovation with our comprehensive Artificial Intelligence (AI) in Remote Patient Monitoring Market Forecast. Stay ahead in the industry!

https://www.delveinsight.com/report-store/ai-in-remote-patient-monitoring-market

Artificial Intelligence (AI) in Remote Patient Monitoring Overview

AI in remote patient monitoring leverages advanced algorithms and machine learning to continuously track and analyze patient health data outside traditional clinical settings. It enables real-time detection of anomalies, predictive insights for early intervention, and personalized care management. By integrating wearable devices, sensors, and cloud platforms, AI-driven RPM improves patient outcomes, reduces hospital visits, and supports efficient chronic disease management.

Artificial Intelligence (AI) in Remote Patient Monitoring Market Insights

The global artificial intelligence in remote patient monitoring market has experienced notable growth in recent years, primarily due to the rising prevalence of chronic conditions like cancer, diabetes, cardiovascular diseases, and respiratory disorders. Moreover, the expanding trend of strategic partnerships and collaborations among pharmaceutical, biotechnology, and medical device companies is significantly contributing to the faster adoption of AI-enabled remote patient monitoring solutions.

DelveInsight Analysis: The global artificial intelligence in remote patient monitoring market size is projected to grow from USD 19,526.51 million in 2025 to USD 13,126.80 million by 2034, achieving a robust compound annual growth rate (CAGR) of 27.13% during the forecast period from 2026 to 2034, reflecting strong and sustained expansion.

To know more about why North America is leading the market growth in the Artificial Intelligence (AI) in Remote Patient Monitoring market, get a snapshot of the report Artificial Intelligence (AI) in Remote Patient Monitoring Market Trends

Recent Developments in the Artificial Intelligence (AI) in Remote Patient Monitoring Market Report

• In September 2025, Roche announced CE-mark approval for the integration of its Accu-Chek SmartGuide CGM system with its mySugr app, incorporating predictive AI algorithms that forecast glucose levels up to two hours ahead and overnight for up to seven hours.

• In June 2025, Bruni, Texas, in Webb County, launched an OnMed CareStation telehealth kiosk that enables residents in a remote community to consult virtually with licensed clinicians and undergo real-time health assessments, thereby illustrating how digital care is extending beyond clinics into underserved areas.

• In May 2025, Tenovi LLC launched a connected blood pressure monitor integrated with their RPM platform (for stroke prevention / cardiovascular risk) with irregular heartbeat detection.

• In April 2025, the Dexcom G7 15-Day Continuous Glucose Monitoring System was cleared by the U.S. Food and Drug Administration (FDA) for adults with diabetes, enhancing wear time and enabling richer data streams for downstream AI-based monitoring analytics.

• In January 2025, Glooko, Inc. announced that the Glooko XT platform (remote monitoring of gestational diabetes) obtained reimbursement approval in France via the Haute Autorité de Santé (HAS) / Commission Nationale d’Évaluation des Dispositifs Médicaux et des Technologies de Santé (CNEDiMTS).

• In January 2025, PanopticAI received FDA clearance for its innovative “Vital Signs” app, marking a major advancement in AI-powered remote patient monitoring. The app functions as a Software as a Medical Device (SaMD) and leverages the built-in camera of iPhones and iPads to perform contactless pulse rate measurement using remote photoplethysmography (rPPG) technology.

• In October 2024, the BioButton Multi-Patient wearable + BioDashboard system received US Food and Drug Administration (FDA) approval. This wearable device extends remote monitoring into home settings supported by AI analytics.

• In March 2023, NeuroRPM Inc. received FDA clearance for its innovative NeuroRPM Apple Watch application, a groundbreaking AI-powered solution designed to remotely monitor key motor symptoms in patients with Parkinson’s disease, including bradykinesia, tremor, and dyskinesia.

Key Players in the Artificial Intelligence (AI) in Remote Patient Monitoring Market

Some of the key market players operating in the Artificial Intelligence (AI) in Remote Patient Monitoring market include- Medtronic, iRhythm Inc., Koninklijke Philips N.V., Siemens Healthineers, GE HealthCare, Apple Inc., alivecor Inc., Biofourmis, Optum, Inc., Headspace Health, Withings, NeuroRPM Inc., Caretaker Medical, Implicity, Stryker, Biobeat, Zingage, Teton.ai, Athelas, Empatica, and others.

To read more about the latest highlights related to Artificial Intelligence (AI) in Remote Patient Monitoring, get a snapshot of the key highlights entailed in the Artificial Intelligence (AI) in Remote Patient Monitoring Market Forecast Report

Market Analysis on the Artificial Intelligence (AI) in Remote Patient Monitoring Market

According to estimates, North America is expected to lead the AI in clinical trial market in 2025, capturing around 47% of the total market share. The region’s growth in artificial intelligence for remote patient monitoring is driven by factors such as the increasing prevalence of chronic diseases like cancer and cardiovascular conditions, a strong healthcare infrastructure, widespread adoption of digital health technologies, and supportive government policies. In addition, significant investments in digital health initiatives and the growing use of wearable and connected medical devices have further enhanced North America’s readiness for AI-powered RPM solutions.

The competitive landscape of AI in Remote Patient Monitoring (RPM) is developing into a moderately consolidated market. A few major medtech companies—such as Philips, Medtronic, Siemens Healthineers, GE Healthcare, Abbott, and Boston Scientific—dominate with comprehensive platform and device solutions, while a dynamic group of specialized startups and software providers target niche AI applications like seizure detection, contactless vital monitoring, CGM analytics, and ECG interpretation, resulting in a two-tier market structure.

Scope of the Artificial Intelligence (AI) in Remote Patient Monitoring Market Report

• Coverage: Global

• Study Period: 2023–2034

• Artificial Intelligence (AI) in Remote Patient Monitoring Market Segmentation By Product & Services: Devices, Software, and Services

• Artificial Intelligence (AI) in Remote Patient Monitoring Market Segmentation By Application: Cardiovascular Disorder, Diabetes, Neurological Disorders, and Others

• Artificial Intelligence (AI) in Remote Patient Monitoring Market Segmentation By End Users: Hospitals & Clinics, Diagnostic Centers, and Homecare Setting

• Artificial Intelligence (AI) in Remote Patient Monitoring Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World

• Key Artificial Intelligence (AI) in Remote Patient Monitoring Companies: Medtronic, iRhythm Inc., Koninklijke Philips N.V., Siemens Healthineers, GE HealthCare, Apple Inc., alivecor Inc., Biofourmis, Optum, Inc., Headspace Health, Withings, NeuroRPM Inc., Caretaker Medical, Implicity, Stryker, Biobeat, Zingage, Teton.ai, Athelas, Empatica, and others

• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the Artificial Intelligence (AI) in Remote Patient Monitoring market are set to emerge as the trendsetter explore @ Artificial Intelligence (AI) in Remote Patient Monitoring Manufacturer

Table of Contents

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/